Microbial load in UTI, LRTI, BSI among acute ischemic stroke patients
Shaik Mohiseen Begum, Amar Sajjan C., Afreen Iqbal

TL;DR
This study examines infection rates in stroke patients, finding that UTIs are most common and E. coli is a frequent pathogen.
Contribution
The study provides insights into microbial patterns in stroke patients, emphasizing early detection to prevent secondary infections.
Findings
UTIs were the most common infection (48.3%) among acute ischemic stroke patients.
E. coli was the most frequently isolated pathogen in stroke patients.
Regular screening and clinical practices can reduce secondary infections in stroke patients.
Abstract
The incidence of urinary tract infections (UTIs), lower respiratory tract infections (LRTI) and blood stream infections in Acute Ischemic Stroke patients is of interest. Hence, a prospective cohort study was conducted on 60 acute ischemic stroke patients admitted within 48 hours from onset of stroke under department of Neurology, tertiary care hospital between Jan 2024 to July 2024. The mean age of the patients was 67.8 years. The average National Institutes of Health Stroke Scale (NIHSS) score was 10.2 ± 3.8 indicating moderate stroke severities. Samples from acute ischemic stroke (AIS) patients were were processed microbiologically for the presence of potential pathogens using standard microbial procedures and antibiotic susceptibility tests performed using disc diffusion technique. Production of AmpC Beta Lactamase, Carbapenemase and Methicillin resistant Staphylococcus aureus was…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAcute Ischemic Stroke Management · Stroke Rehabilitation and Recovery · Botulinum Toxin and Related Neurological Disorders
